RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

ProShare Advisors LLC's Holding History (CIK: 0001357955)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 92,242 Value ($000) $377 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 77,939 Value ($000) $380 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 84,553 Value ($000) $428 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 72,253 Value ($000) $382 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 88,158 Value ($000) $596 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 61,311 Value ($000) $404 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 32,877 Value ($000) $247 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 40,949 Value ($000) $408 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 35,898 Value ($000) $354 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 31,069 Value ($000) $238 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 29,697 Value ($000) $222 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 28,802 Value ($000) $192 Avg Close $7.93 Range $6.40 - $9.73
Q4 2022
Shares 32,611 Value ($000) $251 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 28,904 Value ($000) $308 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 27,950 Value ($000) $227 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 38,107 Value ($000) $272 Avg Close $10.63 Range $5.80 - $18.23
Q4 2021
Shares 47,649 Value ($000) $816 Avg Close $18.82 Range $15.25 - $23.86
Q2 2021
Shares 5,482 Value ($000) $200 Avg Close $29.60 Range $19.68 - $38.39